Last reviewed · How we verify
Unique Pharmaceutical Laboratories, India — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Unique Pharmaceutical Laboratories, India (Unique Pharmaceutical Laboratories, India) — Thinq Pharma-CRO Pte. Ltd.. Unique Pharmaceutical Laboratories' drug is a small molecule in phase 3 clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Unique Pharmaceutical Laboratories, India TARGET | Unique Pharmaceutical Laboratories, India | Thinq Pharma-CRO Pte. Ltd. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Unique Pharmaceutical Laboratories, India CI watch — RSS
- Unique Pharmaceutical Laboratories, India CI watch — Atom
- Unique Pharmaceutical Laboratories, India CI watch — JSON
- Unique Pharmaceutical Laboratories, India alone — RSS
Cite this brief
Drug Landscape (2026). Unique Pharmaceutical Laboratories, India — Competitive Intelligence Brief. https://druglandscape.com/ci/unique-pharmaceutical-laboratories-india. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab